Table 4.
Parameter | Univariate | 95% CI | p | Mutivariate | p | |
---|---|---|---|---|---|---|
Odds Ratio | Odds Ratio | 95% CI | ||||
Male sex (%) | 0.19 | 0.04–0.94 | 0.031 | N. A | ||
ANA | 1.01 | 1.00–1.02 | < 0.001 | 1.00 | 0.99–1.01 | 0.688 |
AMA-M2 (index) | 1.12 | 0.97–1.29 | 0.107 | |||
IgG (mg/dL) | 1.00 | 1.00–1.01 | 0.003 | 1.00 | 0.99–1.01 | 0.540 |
IgM (mg/dL) | 1.03 | 1.01–1.04 | 0.001 | 1.06 | 0.95–1.20 | 0.126 |
CAP (dB/m) | 0.98 | 0.96–0.99 | 0.002 | 0.94 | 0.84–1.04 | 0.052 |
CD4 + T cells of CD45 + cells (%) | 1.12 | 1.03–1.19 | 0.022 | N. A | ||
NK cells of CD45 + cells (%) | 0.76 | 0.58–1.01 | 0.025 | N. A | ||
Th1 of CD4 + T cells (%) | 0.86 | 0.77–0.96 | 0.006 | 1.55 | 0.61–3.93 | 0.138 |
Th17 of CD4 + T cells (%) | 1.65 | 1.11–2.443 | 0.005 | 0.35 | 0.06–2.28 | 0.130 |
Treg of CD4 + T cells (%) | 0.93 | 0.63–1.38 | 0.707 | |||
PD1 + cells of CD4 + T cells (%) | 0.01 | 0.00–0.23 | < 0.001 | 0.01 | 0.00–99.1 | 0.236 |
PD1 + cells of CD8 + T cells (%) | 0.11 | 0.02–0.67 | < 0.001 | 0.01 | 0.00–38.9 | 0.004 |
Bold values indicate the parameter significantly indicates risk factors of AIH-overlap NASH in univariate or multivariate analysis
Logistic regression was used for univariate and multivariate analysis of the association between significant parameters and indicators of NASH. N. A. not assessed